Osteopore Limited (ASX:OSX) has reported its conclusion of a research program funded by the Chilean government to create a 3D printed bone implant to aid regenerative healing. The company is now moving on to clinical studies in the second half of the 2025 calendar year – which Osteopore sees as further solidifying its presence in the Latin American market. Between the lines, the company’s biotech team are looking at different kind of materials a bone implant can be made out of to accelerate the body’s natural healing after bone trauma. The completion of studies referred to on Thursday awards O…